Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MacroStat Receives 2016 Lilly Global Supplier Award

MacroStat Receives 2016 Lilly Global Supplier Award

MacroStat, a leading biometrics CRO fully owned by Tigermed (ChiNext SZ: 300347), has received the 2016 Lilly Global Supplier Award that recognizes MacroStat’s outstanding performance in the area of biometrics services for Eli Lilly and Company (NYSE: LLY).

The bi-annual Lilly Global Supplier Award identifies suppliers who have positively and measurably contributed to Lilly’s corporate objectives to provide a competitive edge. To win the award, MacroStat provided exemplary quality, service, speed, and total cost reduction. MacroStat was one of only 11 companies selected to receive the award for 2016.

“We are very proud to receive the 2016 Lilly Global Supplier Award in recognition of our hard work and commitment to quality and superior customer service. To have Eli Lilly and Company recognize what we strive to do every day is truly an honor,” added Helen Yin VP of Biometrics at Tigermed, Co-Founder of MacroStat.

About MacroStat

MacroStat is a Biometrics focused Contract Research Organization (CRO) based in Shanghai, China. MacroStat was founded in 2005 and became a wholly-owned subsidiary of Tigermed in 2009. As a client-focused company, MacroStat provides regulatory agencies worldwide with a comprehensive portfolio of data management and biostatistics services that support Clinical Development. With extensive experience in aCRF development, SDTM and ADaM specification and programming, MacroStat is committed to on-time deliveries while maintaining high standards of quality.

About Tigermed

Hangzhou Tigermed Consulting Co., Ltd. is a leading global Contract Research Organization (CRO) headquartered in Hangzhou, China. With over 2,000 employees, 55 locations and a market cap in excess of $2 billion USD, Tigermed is dedicated to providing regulatory affairs, Phase I–IV clinical trials, data management, biostatistics, medical translation and GCP training services for healthcare products. Since its inception in 2004, Tigermed has been committed to accelerating product development timelines while reducing R&D costs and risks, helping to bring the miracles of new products to market effectively.

For more information, please visit http://tigermed.net

MacroStat, A Tigermed Company
Azhar Kalim
VP, Business Development
484-999-1994
akalim@tigermed.net